跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,624 条关于
“Oncimmune Holdings PLC”
全部
4,624
临床试验
894
药物
590
机构
1,878
资讯
1,262
去年
Oncimmune Enters Administration After Failed Sale Attempts and Funding Shortfall
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
3年前
hVIVO PLC Develops hMPV Human Challenge Model
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
去年
COMPASS Pathways Reports Financials and Progress on COMP360 Psilocybin Program
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
Tezspire Meets Primary Endpoints in WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
Physiomics' PREDICT-ONC Trial Receives Approval to Optimize Chemotherapy Dosing
去年
VivoPower Advances in $180 Million Takeover Deal with Energi Holdings as Phase I Due Diligence Completes
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
第 1 页,共 127 页
上一页
下一页